An investigational drug for multiple sclerosis from Io Therapeutics has restored leg mobility and myelin nerve coatings in ...

The most-read stories published by Multiple Sclerosis News Today in 2024 focused on living with MS and news on disease risk ...

Affecting approximately 2.9 million people worldwide, multiple sclerosis (MS) occurs when the immune system attacks the ...

Men with MS who started on high-efficacy DMTs had fewer relapses than those who started with moderate-efficacy DMTs, a U.S.

“MS appears to develop when an aberrant immune response raised against EBV attacks the myelin sheaths protecting nerves in the brain,” says Joshi. The virus can cause the body to produce an ...

Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the ...

Multiple sclerosis (MS) is a condition in which the immune system attacks your myelin, the sheath that wraps around nerve cells. The symptoms of MS can vary widely, depending on the nerves that ...

Multiple sclerosis (MS) is a chronic central nervous system (CNS) disease that affects the brain, spinal cord, and optic nerves. Even in the absence of symptoms, the disease is continuously active ...

Sphingosine is a membrane component in all cells and constitutes 25% of the lipid in the myelin sheath. Sphingosine is phosphorylated by ubiquitously expressed sphingosine kinases. S1P regulates ...